Biotech Company on Nasdaq Dives into Cryptocurrency: Investment in HYPE Token Guaranteed with Ambitious Treasury Move
In a groundbreaking move, Hyperliquid Strategies Inc. (HSI) has been established through the merger of Sonnet BioTherapeutics and Rorschach I LLC, announced on July 6, 2025. The strategic pivot from Sonnet's original biotechnology focus to crypto treasury management centres on the HYPE token, the native digital asset of the Hyperliquid Layer-1 blockchain ecosystem.
The merger, valued at $888 million, is backed by major institutional investors such as Paradigm, Galaxy Digital, Pantera Capital, D1 Capital, Republic Digital, and 683 Capital. At closing, HSI is expected to hold approximately 12.6 million HYPE tokens, worth around $583 million, and receive $305 million in cash.
The formation of HSI aims to create one of the largest publicly listed treasury companies in the U.S. with direct exposure to the HYPE token. By converting Sonnet into a publicly traded vehicle that holds substantial HYPE reserves, HSI offers traditional equity investors regulated access to digital asset exposure through the Nasdaq market.
The leadership of HSI includes Bob Diamond as Chairman and David Schamis as CEO, both co-founders of Atlas. The board will also include Eric Rosengren, former President of the Boston Federal Reserve, and two independent directors from Sonnet.
Hyperliquid, an emerging Layer-1 blockchain known for its high-throughput on-chain trading infrastructure, features HyperCore, which powers on-chain perpetual futures and supports up to 200,000 orders per second, and HyperEVM, a general-purpose smart contract platform.
Sonnet BioTherapeutics will continue as a wholly owned subsidiary of HSI, managing some of its existing oncology pipeline. However, the corporate focus will shift decisively to crypto treasury management.
HSI aims to turn into a leading model for crypto-native treasury management in the public markets. It also intends to offer indirect exposure to HYPE for U.S. investors who may not be able to buy the token easily. A Sponsor Advisory Agreement (SAA) will be established with Rorschach to integrate HYPE into long-term treasury strategy.
The merger marks a significant step in the crypto industry, with Hyperliquid Strategies Inc. becoming one of the largest public holders of HYPE globally. As of July 6, HYPE is the 13th-largest cryptocurrency by market cap, a status that few could have predicted. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
- Hyperliquid Strategies Inc. (HSI), a new entity formed through the merger of Sonnet BioTherapeutics and Rorschach I LLC, is backed by institutional investors including Paradigm, Galaxy Digital, Pantera Capital, and others.
- The merger, valued at $888 million, will result in HSI holding approximately 12.6 million HYPE tokens, worth around $583 million, and receiving $305 million in cash.
- HSI's strategic pivot from biotechnology to crypto treasury management centers on the HYPE token, the native digital asset of the Hyperliquid Layer-1 blockchain ecosystem.
- With this move, HSI aims to offer traditional equity investors regulated access to digital asset exposure through the Nasdaq market.
- The leadership of HSI includes Bob Diamond as Chairman, David Schamis as CEO, and Eric Rosengren, former President of the Boston Federal Reserve, among others.
- Hyperliquid, an emerging Layer-1 blockchain, features HyperCore for high-throughput on-chain trading and HyperEVM, a general-purpose smart contract platform.
- Sonnet BioTherapeutics will continue as a subsidiary of HSI, managing its oncology pipeline, while the corporate focus will shift to crypto treasury management.
- The merger positions HSI as a leading model for crypto-native treasury management in the public markets, offering indirect exposure to HYPE for U.S. investors, and is expected to close in the fourth quarter of 2025, subject to customary closing conditions. Post-merger, HSI becomes one of the largest public holders of HYPE globally, with HYPE being the 13th-largest cryptocurrency by market cap.
